PROFOUND MEDICAL CORP (PRN.CA) Stock Analyst Ratings
Canada • Toronto Stock Exchange • TSX:PRN • CA74319B5027
8.77 CAD
+0.02 (+0.23%)
Last: Feb 6, 2026, 07:00 PM
ChartMill assigns a Buy % Consensus number of 80% to PRN.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 15.56. This target is 77.37% above the current price.
- PRN.CA was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PRN.CA.
- In the previous month the buy percentage consensus was at a similar level.
- Only 5 analysts analyzed PRN.CA. So this is just the average opinion of a couple of analysts.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-03-07 | Cown | Initiate | Buy |
| 2022-02-22 | Raymond James Capital | Initiate | Buy |
| 2022-02-22 | Raymond James Financial | Initiate | Buy |
| 2021-10-27 | Raymond James Financial | Downgrade | Strong Buy |
PROFOUND MEDICAL CORP / PRN.CA FAQ
What is the average price target for PROFOUND MEDICAL CORP (PRN.CA) stock?
5 analysts have analysed PRN.CA and the average price target is 15.56 CAD. This implies a price increase of 77.37% is expected in the next year compared to the current price of 8.77.
What is the consensus rating for PROFOUND MEDICAL CORP (PRN.CA) stock?
The consensus rating for PROFOUND MEDICAL CORP (PRN.CA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.